High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy

G. Manfredi, S. Servidei, E. Bonilla, S. Shanske, E. A. Schon, S. DiMauro, Carlos T Moraes

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Other investigators reported the presence of low levels of a 260-bp heteroplasmic duplication of mitochondrial DNA in patients with mitochondrial DNA deletions and their asymptomatic mothers. In this study, we were not able to detect this polymorphism in 30 patients with mitochondrial DNA deletions, but the 260-bp duplication was detected in relatively high levels (32% in muscle) in a patient with a slowly progressive mitochondrial myopathy. The duplication was also present in cultured fibroblasts (10%) and in WBC (<1%). Mitochondrial dysfunction in this patient was evidenced in muscle by the presence of ragged-red fibers and a partial decrease in cytochrome c oxidase activity. We also detected low levels of mitochondrial DNA harboring a triplication of the 260-bp region, indicating that this polymorphism is unstable. Taken together, our results suggest that an unstable 260-bp duplication, which includes important mitochondrial DNA cis-acting regulatory sequences, may be pathogenic per se, if present at high levels.

Original languageEnglish
Pages (from-to)762-768
Number of pages7
JournalNeurology
Volume45
Issue number4
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Mitochondrial Myopathies
Mitochondrial DNA
Muscles
Electron Transport Complex IV
Fibroblasts
Mothers
Research Personnel

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Manfredi, G., Servidei, S., Bonilla, E., Shanske, S., Schon, E. A., DiMauro, S., & Moraes, C. T. (1995). High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. Neurology, 45(4), 762-768.

High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. / Manfredi, G.; Servidei, S.; Bonilla, E.; Shanske, S.; Schon, E. A.; DiMauro, S.; Moraes, Carlos T.

In: Neurology, Vol. 45, No. 4, 01.01.1995, p. 762-768.

Research output: Contribution to journalArticle

Manfredi, G, Servidei, S, Bonilla, E, Shanske, S, Schon, EA, DiMauro, S & Moraes, CT 1995, 'High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy', Neurology, vol. 45, no. 4, pp. 762-768.
Manfredi G, Servidei S, Bonilla E, Shanske S, Schon EA, DiMauro S et al. High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. Neurology. 1995 Jan 1;45(4):762-768.
Manfredi, G. ; Servidei, S. ; Bonilla, E. ; Shanske, S. ; Schon, E. A. ; DiMauro, S. ; Moraes, Carlos T. / High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy. In: Neurology. 1995 ; Vol. 45, No. 4. pp. 762-768.
@article{981119ce92124b37bc6e3b690b7cb83e,
title = "High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy",
abstract = "Other investigators reported the presence of low levels of a 260-bp heteroplasmic duplication of mitochondrial DNA in patients with mitochondrial DNA deletions and their asymptomatic mothers. In this study, we were not able to detect this polymorphism in 30 patients with mitochondrial DNA deletions, but the 260-bp duplication was detected in relatively high levels (32{\%} in muscle) in a patient with a slowly progressive mitochondrial myopathy. The duplication was also present in cultured fibroblasts (10{\%}) and in WBC (<1{\%}). Mitochondrial dysfunction in this patient was evidenced in muscle by the presence of ragged-red fibers and a partial decrease in cytochrome c oxidase activity. We also detected low levels of mitochondrial DNA harboring a triplication of the 260-bp region, indicating that this polymorphism is unstable. Taken together, our results suggest that an unstable 260-bp duplication, which includes important mitochondrial DNA cis-acting regulatory sequences, may be pathogenic per se, if present at high levels.",
author = "G. Manfredi and S. Servidei and E. Bonilla and S. Shanske and Schon, {E. A.} and S. DiMauro and Moraes, {Carlos T}",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "45",
pages = "762--768",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - High levels of mitochondrial DNA with an unstable 260-bp duplication in a patient with a mitochondrial myopathy

AU - Manfredi, G.

AU - Servidei, S.

AU - Bonilla, E.

AU - Shanske, S.

AU - Schon, E. A.

AU - DiMauro, S.

AU - Moraes, Carlos T

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Other investigators reported the presence of low levels of a 260-bp heteroplasmic duplication of mitochondrial DNA in patients with mitochondrial DNA deletions and their asymptomatic mothers. In this study, we were not able to detect this polymorphism in 30 patients with mitochondrial DNA deletions, but the 260-bp duplication was detected in relatively high levels (32% in muscle) in a patient with a slowly progressive mitochondrial myopathy. The duplication was also present in cultured fibroblasts (10%) and in WBC (<1%). Mitochondrial dysfunction in this patient was evidenced in muscle by the presence of ragged-red fibers and a partial decrease in cytochrome c oxidase activity. We also detected low levels of mitochondrial DNA harboring a triplication of the 260-bp region, indicating that this polymorphism is unstable. Taken together, our results suggest that an unstable 260-bp duplication, which includes important mitochondrial DNA cis-acting regulatory sequences, may be pathogenic per se, if present at high levels.

AB - Other investigators reported the presence of low levels of a 260-bp heteroplasmic duplication of mitochondrial DNA in patients with mitochondrial DNA deletions and their asymptomatic mothers. In this study, we were not able to detect this polymorphism in 30 patients with mitochondrial DNA deletions, but the 260-bp duplication was detected in relatively high levels (32% in muscle) in a patient with a slowly progressive mitochondrial myopathy. The duplication was also present in cultured fibroblasts (10%) and in WBC (<1%). Mitochondrial dysfunction in this patient was evidenced in muscle by the presence of ragged-red fibers and a partial decrease in cytochrome c oxidase activity. We also detected low levels of mitochondrial DNA harboring a triplication of the 260-bp region, indicating that this polymorphism is unstable. Taken together, our results suggest that an unstable 260-bp duplication, which includes important mitochondrial DNA cis-acting regulatory sequences, may be pathogenic per se, if present at high levels.

UR - http://www.scopus.com/inward/record.url?scp=0028948888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028948888&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 762

EP - 768

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -